Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tobramycin (0.3% w/v) + Moxifloxacin (0.5% w/v)
Therapeutic Category
Ophthalmology, Antibiotic
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tobraxyle M Eye Drop Tobramycin 0.3% w/v Moxifloxacin 0.5% w/v is a premium, dual-antibiotic ophthalmic combination providing broad and powerful coverage against a wide spectrum of bacteria causing severe ocular infections. Tobramycin, an aminoglycoside, and Moxifloxacin, a fourth-generation fluoroquinolone, work synergistically to treat bacterial conjunctivitis, keratitis, and pre/post-operative infection prophylaxis.
This combination is highly valued by Ophthalmologists as a first-line choice for aggressive or mixed infections where resistant strains may be present. The dual mechanism of action minimizes the risk of treatment failure and provides faster patient response, leading to strong specialist preference.
The product commands a higher price point and is essential for high-value surgical care and urgent care settings, ensuring a profitable specialist segment. Secure your exclusive Tobraxyle M territory and dominate the critical segment of the high-efficacy ophthalmic anti-infective market.
Some patients may experience mild stinging, burning, eye irritation, or temporary blurred vision. Rarely, allergic reactions such as eye swelling, redness, or itching may occur. If symptoms persist or worsen, discontinue use and consult an ophthalmologist immediately.
Tobraxyle M Eye Drop is indicated for the treatment of bacterial conjunctivitis, keratitis, blepharitis, and other ocular infections caused by susceptible bacteria. It helps in reducing redness, pain, discharge, and irritation, promoting faster healing and preventing complications.
Use Tobraxyle M Eye Drop exactly as prescribed by your healthcare provider. Typically, 1–2 drops in the affected eye(s) every 4–6 hours or as advised. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Complete the full course of treatment even if symptoms improve early.
Store Tobraxyle M Eye Drop in a cool, dry place below 25°C, protected from light. Keep out of reach of children and discard after the expiry date or if the solution appears discolored or cloudy.
Composition : Levocetirizine (2.5mg/5ml)
Composition : Levocetirizine (10mg)
Composition : Levocetirizine (5mg)
Composition : Levocetirizine (5mg) + Ambroxol (60mg)
Composition : Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Composition : Levocetirizine (5mg) + Montelukast (10mg) Bilayered
Composition : Acebrophylline (200mg) + Desloratadine (5mg) + Montelukast (10mg) Tablet
Composition : Bilastine (20mg) Tablet
Composition : Bilastine (40mg) Tablet
Composition : Bilastine (20mg) + Montelukast (10mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.